Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
In this Viewpoint article, Alastair Buchan and James Kennedy evaluate emerging options for the treatment of acute ischemic stroke and discuss the difficulties associated with choosing the patients who might benefit most from them.
Primary CNS lymphoma, an extranodal non-Hodgkin's lymphoma that invades the nervous system, accounts for around 3% of all primary brain tumors. In this Review, Hochberg et al. highlight recent advances in our understanding of the pathogenesis of primary CNS lymphoma, and they discuss current approaches to the diagnosis and therapy of this condition.
Intravenous immunoglobulin has an important role in the treatment of numerous neuroimmunological disorders, including Guillain–Barré syndrome and multiple sclerosis. In this article, Gold et al. review current and future indications for intravenous immunoglobulin treatment, discuss its proposed mechanisms of action, and highlight various practical issues relating to its use in the clinic.
Revascularization has a pivotal role in ischemic stroke therapy, and strokes involving small blood vessels respond well to intravenously administered thrombolytic drugs. Large-vessel strokes carry higher morbidity and mortality than small-vessel strokes, and are less amenable to thrombolytic approaches. In this Review, Wade Smith assesses recent data indicating that recanalization of large vessels can be achieved using mechanical clot retrieval devices.
